{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3289, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de074-2691-7523-92d7-a01a3837be3d", "docSlug": "fa8fb15584528290578ab0c38f82e3e3", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 22 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide uses a pyramid structure to represent market size by patient population, with larger populations at the base.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2691-7523-92d7-a01a3837be3d/13", "deckHref": "/decks/019de074-2691-7523-92d7-a01a3837be3d", "deckAnchorHref": "/decks/019de074-2691-7523-92d7-a01a3837be3d#slide-13", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 8, "beatId": "6cf61571-e8cf-4db7-ae2a-abea628cb60e", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "What Could Be", "beatSlug": "sparkline-what-could-be-2", "evidence": "The presentation then explores the potential of the company's approach (what could be).", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2691-7523-92d7-a01a3837be3d", "docSlug": "fa8fb15584528290578ab0c38f82e3e3", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 22 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "timeline", "function": "plan_implementation", "notes": "The slide uses a horizontal timeline structure with vertical segmentation by development stage. Patient numbers represent U.S. prevalence.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2691-7523-92d7-a01a3837be3d/14", "deckHref": "/decks/019de074-2691-7523-92d7-a01a3837be3d", "deckAnchorHref": "/decks/019de074-2691-7523-92d7-a01a3837be3d#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 8, "beatId": "6cf61571-e8cf-4db7-ae2a-abea628cb60e", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "What Could Be", "beatSlug": "sparkline-what-could-be-2", "evidence": "The presentation then explores the potential of the company's approach (what could be).", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2691-7523-92d7-a01a3837be3d", "docSlug": "fa8fb15584528290578ab0c38f82e3e3", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 22 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "propose_solution", "function": "present_solution", "notes": "The slide highlights the mechanism of action (pH/Ca2+ switch, no effector function, optimal recycling) and the clinical pipeline status for MMN, delayed graft function, and dermatomyositis.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2691-7523-92d7-a01a3837be3d/15", "deckHref": "/decks/019de074-2691-7523-92d7-a01a3837be3d", "deckAnchorHref": "/decks/019de074-2691-7523-92d7-a01a3837be3d#slide-15", "loopMatches": [ { "to": 15, "from": 15, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "a0c08e58-982f-4e3c-a9f8-0cc9206ac25a", "evidence": "The proposal of a solution on page 15 highlights the potential benefits of ARGX-117.", "position": 2, "objective": "Understanding the potential impact of ARGX-117", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.6, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 22, "from": 15, "beatId": "2b02df3a-6f99-4079-be65-27ef4febe9fa", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "New Bliss", "beatSlug": "sparkline-new-bliss", "evidence": "The presentation concludes with a vision for the future (new bliss).", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2691-7523-92d7-a01a3837be3d", "docSlug": "fa8fb15584528290578ab0c38f82e3e3", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 22 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "other", "function": "analyze_data", "notes": "The slide uses immunofluorescence microscopy to show structural damage and bar charts/traces to show functional respiratory recovery.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2691-7523-92d7-a01a3837be3d/16", "deckHref": "/decks/019de074-2691-7523-92d7-a01a3837be3d", "deckAnchorHref": "/decks/019de074-2691-7523-92d7-a01a3837be3d#slide-16", "loopMatches": [], "arcBeatMatches": [ { "to": 22, "from": 15, "beatId": "2b02df3a-6f99-4079-be65-27ef4febe9fa", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "New Bliss", "beatSlug": "sparkline-new-bliss", "evidence": "The presentation concludes with a vision for the future (new bliss).", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2691-7523-92d7-a01a3837be3d", "docSlug": "fa8fb15584528290578ab0c38f82e3e3", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 22 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "other", "function": "present_framework", "notes": "Includes a biological mechanism diagram on the left and a clinical trial design timeline/process on the right.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2691-7523-92d7-a01a3837be3d/17", "deckHref": "/decks/019de074-2691-7523-92d7-a01a3837be3d", "deckAnchorHref": "/decks/019de074-2691-7523-92d7-a01a3837be3d#slide-17", "loopMatches": [], "arcBeatMatches": [ { "to": 22, "from": 15, "beatId": "2b02df3a-6f99-4079-be65-27ef4febe9fa", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "New Bliss", "beatSlug": "sparkline-new-bliss", "evidence": "The presentation concludes with a vision for the future (new bliss).", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2691-7523-92d7-a01a3837be3d", "docSlug": "fa8fb15584528290578ab0c38f82e3e3", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 22 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "key_messages", "function": "present_framework", "notes": "The slide uses a series of four circular icons atop vertical color-coded columns to categorize medical indications by therapeutic area.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2691-7523-92d7-a01a3837be3d/18", "deckHref": "/decks/019de074-2691-7523-92d7-a01a3837be3d", "deckAnchorHref": "/decks/019de074-2691-7523-92d7-a01a3837be3d#slide-18", "loopMatches": [], "arcBeatMatches": [ { "to": 22, "from": 15, "beatId": "2b02df3a-6f99-4079-be65-27ef4febe9fa", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "New Bliss", "beatSlug": "sparkline-new-bliss", "evidence": "The presentation concludes with a vision for the future (new bliss).", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2691-7523-92d7-a01a3837be3d", "docSlug": "fa8fb15584528290578ab0c38f82e3e3", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 22 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "other", "function": "establish_context", "notes": "The slide uses a hub-and-spoke style layout to show relationships between entities.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2691-7523-92d7-a01a3837be3d/19", "deckHref": "/decks/019de074-2691-7523-92d7-a01a3837be3d", "deckAnchorHref": "/decks/019de074-2691-7523-92d7-a01a3837be3d#slide-19", "loopMatches": [], "arcBeatMatches": [ { "to": 22, "from": 15, "beatId": "2b02df3a-6f99-4079-be65-27ef4febe9fa", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "New Bliss", "beatSlug": "sparkline-new-bliss", "evidence": "The presentation concludes with a vision for the future (new bliss).", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2691-7523-92d7-a01a3837be3d", "docSlug": "fa8fb15584528290578ab0c38f82e3e3", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 22 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a dual-section layout separating commercial and clinical activities, with specific dates aligned to each milestone.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2691-7523-92d7-a01a3837be3d/20", "deckHref": "/decks/019de074-2691-7523-92d7-a01a3837be3d", "deckAnchorHref": "/decks/019de074-2691-7523-92d7-a01a3837be3d#slide-20", "loopMatches": [], "arcBeatMatches": [ { "to": 22, "from": 15, "beatId": "2b02df3a-6f99-4079-be65-27ef4febe9fa", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "New Bliss", "beatSlug": "sparkline-new-bliss", "evidence": "The presentation concludes with a vision for the future (new bliss).", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2691-7523-92d7-a01a3837be3d", "docSlug": "fa8fb15584528290578ab0c38f82e3e3", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 22 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "other", "function": "other", "notes": "The diagram features five core values: Co-Creation, Empowerment, Excellence, Humility, and Innovation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2691-7523-92d7-a01a3837be3d/21", "deckHref": "/decks/019de074-2691-7523-92d7-a01a3837be3d", "deckAnchorHref": "/decks/019de074-2691-7523-92d7-a01a3837be3d#slide-21", "loopMatches": [], "arcBeatMatches": [ { "to": 22, "from": 15, "beatId": "2b02df3a-6f99-4079-be65-27ef4febe9fa", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "New Bliss", "beatSlug": "sparkline-new-bliss", "evidence": "The presentation concludes with a vision for the future (new bliss).", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2691-7523-92d7-a01a3837be3d", "docSlug": "fa8fb15584528290578ab0c38f82e3e3", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 22 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "roadmap", "function": "plan_implementation", "notes": "The chart uses a horizontal bar format to represent clinical trial progress from Preclinical to Commercial stages.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2691-7523-92d7-a01a3837be3d/22", "deckHref": "/decks/019de074-2691-7523-92d7-a01a3837be3d", "deckAnchorHref": "/decks/019de074-2691-7523-92d7-a01a3837be3d#slide-22", "loopMatches": [], "arcBeatMatches": [ { "to": 22, "from": 15, "beatId": "2b02df3a-6f99-4079-be65-27ef4febe9fa", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "New Bliss", "beatSlug": "sparkline-new-bliss", "evidence": "The presentation concludes with a vision for the future (new bliss).", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2763-7087-8fbd-df19b6e58266", "docSlug": "1ca51573de190fbfcf19415b61000ddd", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 18 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/XNWxPTiCcjBE3i_6Vrlg-JQkot1voTZDxN5U6LXMjaI/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8xY2E1MTU3M2RlMTkwZmJmY2YxOTQxNWI2MTAwMGRkZC9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2763-7087-8fbd-df19b6e58266/1", "deckHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchorHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 3, "from": 1, "beatId": "c522e53a-9637-425f-9c8a-3dd0c2f9d5e6", "arcName": "The Golden Circle", "arcSlug": "golden-circle", "beatName": "Why", "beatSlug": "golden-circle-why", "evidence": "The presentation begins with AstraZeneca's mission and strategic focus (Science-led, patient-centered).", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/D1INx3bSZDJInhAYRY5NRRAYOXnYgpfh3THIqh0jVWI/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8xY2E1MTU3M2RlMTkwZmJmY2YxOTQxNWI2MTAwMGRkZC9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/yF6Ee7RB4i4A1URq1QcR6luTCV8sX7LmJeNIY33uzv0/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8xY2E1MTU3M2RlMTkwZmJmY2YxOTQxNWI2MTAwMGRkZC9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/zsh_HFYyAlN16H1eo8QmJrdXAyPm61txi8Ay8BN5apw/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8xY2E1MTU3M2RlMTkwZmJmY2YxOTQxNWI2MTAwMGRkZC9wMDAxLnBuZw" }, { "docId": "019de074-2763-7087-8fbd-df19b6e58266", "docSlug": "1ca51573de190fbfcf19415b61000ddd", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 18 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2763-7087-8fbd-df19b6e58266/2", "deckHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchorHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 3, "from": 1, "beatId": "c522e53a-9637-425f-9c8a-3dd0c2f9d5e6", "arcName": "The Golden Circle", "arcSlug": "golden-circle", "beatName": "Why", "beatSlug": "golden-circle-why", "evidence": "The presentation begins with AstraZeneca's mission and strategic focus (Science-led, patient-centered).", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2763-7087-8fbd-df19b6e58266", "docSlug": "1ca51573de190fbfcf19415b61000ddd", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 18 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "executive_summary", "function": "summarize", "notes": "The slide uses a four-column layout to summarize key corporate metrics and strategic focus areas.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2763-7087-8fbd-df19b6e58266/3", "deckHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchorHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-3", "loopMatches": [ { "to": 14, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "88983257-4d74-4000-ae54-8166a2051abc", "evidence": "The loop is visible in how the presentation starts with the company's mission and weaves through its growth strategy.", "position": 0, "objective": "To explain why AstraZeneca is positioned for growth and how it plans to achieve it", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.8, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 3, "from": 1, "beatId": "c522e53a-9637-425f-9c8a-3dd0c2f9d5e6", "arcName": "The Golden Circle", "arcSlug": "golden-circle", "beatName": "Why", "beatSlug": "golden-circle-why", "evidence": "The presentation begins with AstraZeneca's mission and strategic focus (Science-led, patient-centered).", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" }, { "to": 11, "from": 3, "beatId": "577d5e60-d812-43a3-83a5-243b94cfd455", "arcName": "The Golden Circle", "arcSlug": "golden-circle", "beatName": "Executive Summary", "beatSlug": null, "evidence": "Summarizing the company's position and strategy for growth.", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2763-7087-8fbd-df19b6e58266", "docSlug": "1ca51573de190fbfcf19415b61000ddd", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 18 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "key_messages", "function": "summarize", "notes": "Slide 4 of a presentation, likely AstraZeneca.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2763-7087-8fbd-df19b6e58266/4", "deckHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchorHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-4", "loopMatches": [ { "to": 14, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "88983257-4d74-4000-ae54-8166a2051abc", "evidence": "The loop is visible in how the presentation starts with the company's mission and weaves through its growth strategy.", "position": 0, "objective": "To explain why AstraZeneca is positioned for growth and how it plans to achieve it", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.8, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 6, "from": 4, "beatId": "e228d2f7-fd43-46a1-9949-226262cb4c09", "arcName": "The Golden Circle", "arcSlug": "golden-circle", "beatName": "Key Messages", "beatSlug": null, "evidence": "The deck then elaborates on key messages including entrepreneurial culture and effective deployment of capital.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null }, { "to": 11, "from": 3, "beatId": "577d5e60-d812-43a3-83a5-243b94cfd455", "arcName": "The Golden Circle", "arcSlug": "golden-circle", "beatName": "Executive Summary", "beatSlug": null, "evidence": "Summarizing the company's position and strategy for growth.", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2763-7087-8fbd-df19b6e58266", "docSlug": "1ca51573de190fbfcf19415b61000ddd", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 18 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses bar charts to compare historical annual performance against 9M 2022 results.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2763-7087-8fbd-df19b6e58266/5", "deckHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchorHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-5", "loopMatches": [ { "to": 14, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "88983257-4d74-4000-ae54-8166a2051abc", "evidence": "The loop is visible in how the presentation starts with the company's mission and weaves through its growth strategy.", "position": 0, "objective": "To explain why AstraZeneca is positioned for growth and how it plans to achieve it", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.8, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 6, "from": 4, "beatId": "e228d2f7-fd43-46a1-9949-226262cb4c09", "arcName": "The Golden Circle", "arcSlug": "golden-circle", "beatName": "Key Messages", "beatSlug": null, "evidence": "The deck then elaborates on key messages including entrepreneurial culture and effective deployment of capital.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null }, { "to": 8, "from": 5, "beatId": "48ed926e-7814-46ee-a629-10f94cf90551", "arcName": "The Golden Circle", "arcSlug": "golden-circle", "beatName": "KPI Overview", "beatSlug": null, "evidence": "Financials and KPIs are presented to show strong performance and momentum.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null }, { "to": 11, "from": 3, "beatId": "577d5e60-d812-43a3-83a5-243b94cfd455", "arcName": "The Golden Circle", "arcSlug": "golden-circle", "beatName": "Executive Summary", "beatSlug": null, "evidence": "Summarizing the company's position and strategy for growth.", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2763-7087-8fbd-df19b6e58266", "docSlug": "1ca51573de190fbfcf19415b61000ddd", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 18 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "key_messages", "function": "present_framework", "notes": "Uses a 2x2 grid layout to categorize capital allocation strategies.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2763-7087-8fbd-df19b6e58266/6", "deckHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchorHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-6", "loopMatches": [ { "to": 14, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "88983257-4d74-4000-ae54-8166a2051abc", "evidence": "The loop is visible in how the presentation starts with the company's mission and weaves through its growth strategy.", "position": 0, "objective": "To explain why AstraZeneca is positioned for growth and how it plans to achieve it", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.8, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 6, "from": 4, "beatId": "e228d2f7-fd43-46a1-9949-226262cb4c09", "arcName": "The Golden Circle", "arcSlug": "golden-circle", "beatName": "Key Messages", "beatSlug": null, "evidence": "The deck then elaborates on key messages including entrepreneurial culture and effective deployment of capital.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null }, { "to": 8, "from": 5, "beatId": "48ed926e-7814-46ee-a629-10f94cf90551", "arcName": "The Golden Circle", "arcSlug": "golden-circle", "beatName": "KPI Overview", "beatSlug": null, "evidence": "Financials and KPIs are presented to show strong performance and momentum.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null }, { "to": 11, "from": 3, "beatId": "577d5e60-d812-43a3-83a5-243b94cfd455", "arcName": "The Golden Circle", "arcSlug": "golden-circle", "beatName": "Executive Summary", "beatSlug": null, "evidence": "Summarizing the company's position and strategy for growth.", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2763-7087-8fbd-df19b6e58266", "docSlug": "1ca51573de190fbfcf19415b61000ddd", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 18 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "key_messages", "function": "present_framework", "notes": "The slide uses a 'Growth Through Innovation' framework to categorize R&D focus areas.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2763-7087-8fbd-df19b6e58266/7", "deckHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchorHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-7", "loopMatches": [ { "to": 14, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "88983257-4d74-4000-ae54-8166a2051abc", "evidence": "The loop is visible in how the presentation starts with the company's mission and weaves through its growth strategy.", "position": 0, "objective": "To explain why AstraZeneca is positioned for growth and how it plans to achieve it", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.8, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 8, "from": 5, "beatId": "48ed926e-7814-46ee-a629-10f94cf90551", "arcName": "The Golden Circle", "arcSlug": "golden-circle", "beatName": "KPI Overview", "beatSlug": null, "evidence": "Financials and KPIs are presented to show strong performance and momentum.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null }, { "to": 11, "from": 3, "beatId": "577d5e60-d812-43a3-83a5-243b94cfd455", "arcName": "The Golden Circle", "arcSlug": "golden-circle", "beatName": "Executive Summary", "beatSlug": null, "evidence": "Summarizing the company's position and strategy for growth.", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2763-7087-8fbd-df19b6e58266", "docSlug": "1ca51573de190fbfcf19415b61000ddd", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 18 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "kpi_overview", "function": "summarize", "notes": "The slide uses a matrix-like structure to compare past performance (9M 2022) with future focus (2023).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2763-7087-8fbd-df19b6e58266/8", "deckHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchorHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-8", "loopMatches": [ { "to": 14, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "88983257-4d74-4000-ae54-8166a2051abc", "evidence": "The loop is visible in how the presentation starts with the company's mission and weaves through its growth strategy.", "position": 0, "objective": "To explain why AstraZeneca is positioned for growth and how it plans to achieve it", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.8, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 8, "from": 5, "beatId": "48ed926e-7814-46ee-a629-10f94cf90551", "arcName": "The Golden Circle", "arcSlug": "golden-circle", "beatName": "KPI Overview", "beatSlug": null, "evidence": "Financials and KPIs are presented to show strong performance and momentum.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null }, { "to": 11, "from": 3, "beatId": "577d5e60-d812-43a3-83a5-243b94cfd455", "arcName": "The Golden Circle", "arcSlug": "golden-circle", "beatName": "Executive Summary", "beatSlug": null, "evidence": "Summarizing the company's position and strategy for growth.", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2763-7087-8fbd-df19b6e58266", "docSlug": "1ca51573de190fbfcf19415b61000ddd", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 18 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "thesis_headline", "function": "present_solution", "notes": "The slide highlights the strategic fit of the CinCor acquisition (baxdrostat) into the existing CVRM pipeline.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2763-7087-8fbd-df19b6e58266/9", "deckHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchorHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-9", "loopMatches": [ { "to": 14, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "88983257-4d74-4000-ae54-8166a2051abc", "evidence": "The loop is visible in how the presentation starts with the company's mission and weaves through its growth strategy.", "position": 0, "objective": "To explain why AstraZeneca is positioned for growth and how it plans to achieve it", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.8, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" }, { "to": 10, "from": 9, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "f577db34-3711-4966-ab1d-a155e7015552", "evidence": "The presentation highlights the strategic rationale for the acquisition at this time.", "position": 1, "objective": "To justify the timing of the acquisition of CinCor Pharma", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 0.7, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [ { "to": 10, "from": 9, "beatId": "d24e6f2d-ed7f-45f3-8426-4526ac01fda7", "arcName": "The Golden Circle", "arcSlug": "golden-circle", "beatName": "Thesis Headline", "beatSlug": null, "evidence": "A specific strategic action (acquisition) is highlighted to strengthen the pipeline.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null }, { "to": 11, "from": 3, "beatId": "577d5e60-d812-43a3-83a5-243b94cfd455", "arcName": "The Golden Circle", "arcSlug": "golden-circle", "beatName": "Executive Summary", "beatSlug": null, "evidence": "Summarizing the company's position and strategy for growth.", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2763-7087-8fbd-df19b6e58266", "docSlug": "1ca51573de190fbfcf19415b61000ddd", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 18 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "executive_summary", "function": "summarize", "notes": "Includes clinical trial data visualization and deal structure details.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2763-7087-8fbd-df19b6e58266/10", "deckHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchorHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-10", "loopMatches": [ { "to": 14, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "88983257-4d74-4000-ae54-8166a2051abc", "evidence": "The loop is visible in how the presentation starts with the company's mission and weaves through its growth strategy.", "position": 0, "objective": "To explain why AstraZeneca is positioned for growth and how it plans to achieve it", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.8, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" }, { "to": 10, "from": 9, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "f577db34-3711-4966-ab1d-a155e7015552", "evidence": "The presentation highlights the strategic rationale for the acquisition at this time.", "position": 1, "objective": "To justify the timing of the acquisition of CinCor Pharma", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 0.7, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [ { "to": 10, "from": 9, "beatId": "d24e6f2d-ed7f-45f3-8426-4526ac01fda7", "arcName": "The Golden Circle", "arcSlug": "golden-circle", "beatName": "Thesis Headline", "beatSlug": null, "evidence": "A specific strategic action (acquisition) is highlighted to strengthen the pipeline.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null }, { "to": 11, "from": 3, "beatId": "577d5e60-d812-43a3-83a5-243b94cfd455", "arcName": "The Golden Circle", "arcSlug": "golden-circle", "beatName": "Executive Summary", "beatSlug": null, "evidence": "Summarizing the company's position and strategy for growth.", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2763-7087-8fbd-df19b6e58266", "docSlug": "1ca51573de190fbfcf19415b61000ddd", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 18 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a list-based layout to categorize clinical milestones.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2763-7087-8fbd-df19b6e58266/11", "deckHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchorHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-11", "loopMatches": [ { "to": 14, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "88983257-4d74-4000-ae54-8166a2051abc", "evidence": "The loop is visible in how the presentation starts with the company's mission and weaves through its growth strategy.", "position": 0, "objective": "To explain why AstraZeneca is positioned for growth and how it plans to achieve it", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.8, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 11, "from": 3, "beatId": "577d5e60-d812-43a3-83a5-243b94cfd455", "arcName": "The Golden Circle", "arcSlug": "golden-circle", "beatName": "Executive Summary", "beatSlug": null, "evidence": "Summarizing the company's position and strategy for growth.", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2763-7087-8fbd-df19b6e58266", "docSlug": "1ca51573de190fbfcf19415b61000ddd", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 18 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a combination of a timeline (H1/H2 2023) and a list for the pipeline. It includes a comprehensive legend for abbreviations at the bottom.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2763-7087-8fbd-df19b6e58266/12", "deckHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchorHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-12", "loopMatches": [ { "to": 14, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "88983257-4d74-4000-ae54-8166a2051abc", "evidence": "The loop is visible in how the presentation starts with the company's mission and weaves through its growth strategy.", "position": 0, "objective": "To explain why AstraZeneca is positioned for growth and how it plans to achieve it", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.8, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 13, "from": 12, "beatId": "c2902914-1df6-44f4-9a90-1f972465d662", "arcName": "The Golden Circle", "arcSlug": "golden-circle", "beatName": "Roadmap", "beatSlug": null, "evidence": "The deck outlines key upcoming newsflow and pipeline, showing a clear growth trajectory.", "position": 5, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2763-7087-8fbd-df19b6e58266", "docSlug": "1ca51573de190fbfcf19415b61000ddd", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 18 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "key_messages", "function": "summarize", "notes": "The slide uses a combination of a horizontal bar chart for product durability and a vertical bar chart for revenue growth projections.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2763-7087-8fbd-df19b6e58266/13", "deckHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchorHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-13", "loopMatches": [ { "to": 14, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "88983257-4d74-4000-ae54-8166a2051abc", "evidence": "The loop is visible in how the presentation starts with the company's mission and weaves through its growth strategy.", "position": 0, "objective": "To explain why AstraZeneca is positioned for growth and how it plans to achieve it", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.8, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 13, "from": 12, "beatId": "c2902914-1df6-44f4-9a90-1f972465d662", "arcName": "The Golden Circle", "arcSlug": "golden-circle", "beatName": "Roadmap", "beatSlug": null, "evidence": "The deck outlines key upcoming newsflow and pipeline, showing a clear growth trajectory.", "position": 5, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2763-7087-8fbd-df19b6e58266", "docSlug": "1ca51573de190fbfcf19415b61000ddd", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 18 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "thesis_headline", "function": "present_solution", "notes": "The slide uses a numbered list to outline strategic pillars leading to a specific financial outcome.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2763-7087-8fbd-df19b6e58266/14", "deckHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchorHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-14", "loopMatches": [ { "to": 14, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "88983257-4d74-4000-ae54-8166a2051abc", "evidence": "The loop is visible in how the presentation starts with the company's mission and weaves through its growth strategy.", "position": 0, "objective": "To explain why AstraZeneca is positioned for growth and how it plans to achieve it", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.8, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2763-7087-8fbd-df19b6e58266", "docSlug": "1ca51573de190fbfcf19415b61000ddd", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 18 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "closing_ask", "function": "state_next_steps", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2763-7087-8fbd-df19b6e58266/15", "deckHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchorHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-15", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 15, "beatId": "d25d54ad-e329-4cda-a857-30b5fce1a06b", "arcName": "The Golden Circle", "arcSlug": "golden-circle", "beatName": "Closing Ask", "beatSlug": null, "evidence": "The presentation concludes with a call for Q&A, engaging investors directly.", "position": 6, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2763-7087-8fbd-df19b6e58266", "docSlug": "1ca51573de190fbfcf19415b61000ddd", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 18 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "team_bio", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2763-7087-8fbd-df19b6e58266/16", "deckHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchorHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-16", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2763-7087-8fbd-df19b6e58266", "docSlug": "1ca51573de190fbfcf19415b61000ddd", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 18 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2763-7087-8fbd-df19b6e58266/17", "deckHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchorHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-17", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2763-7087-8fbd-df19b6e58266", "docSlug": "1ca51573de190fbfcf19415b61000ddd", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 18 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2763-7087-8fbd-df19b6e58266/18", "deckHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchorHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-18", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2806-77f1-979f-2c5838bae35a", "docSlug": "7e995254b839b7fbb7e998df4127a7b8", "documentTitle": "ATAI | Investor Presentation Deck | 33 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/jxXiR5tL_YidZIrfLwCezlTVNXgNykuoig9uj1alV6w/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83ZTk5NTI1NGI4MzliN2ZiYjdlOTk4ZGY0MTI3YTdiOC9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2806-77f1-979f-2c5838bae35a/1", "deckHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a", "deckAnchorHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/_Mn031TbbVxmfJPSJE-G7j-zkOxkV-9vO7N81JCiHL8/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83ZTk5NTI1NGI4MzliN2ZiYjdlOTk4ZGY0MTI3YTdiOC9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/iGhxy_2hmr5RsK-ZpLP3VEuKhJF2OJ1QLOCRxE1GvQw/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83ZTk5NTI1NGI4MzliN2ZiYjdlOTk4ZGY0MTI3YTdiOC9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/hRt7ttyB8YTxRCSs9ZcLlIoVul8q6NdxislKXbUYLFw/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83ZTk5NTI1NGI4MzliN2ZiYjdlOTk4ZGY0MTI3YTdiOC9wMDAxLnBuZw" }, { "docId": "019de074-2806-77f1-979f-2c5838bae35a", "docSlug": "7e995254b839b7fbb7e998df4127a7b8", "documentTitle": "ATAI | Investor Presentation Deck | 33 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "appendix_disclosure", "function": "other", "notes": "Includes a footer note specifying the date of the presentation as January 6th, 2023.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2806-77f1-979f-2c5838bae35a/2", "deckHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a", "deckAnchorHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2806-77f1-979f-2c5838bae35a", "docSlug": "7e995254b839b7fbb7e998df4127a7b8", "documentTitle": "ATAI | Investor Presentation Deck | 33 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "executive_summary", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2806-77f1-979f-2c5838bae35a/3", "deckHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a", "deckAnchorHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2806-77f1-979f-2c5838bae35a", "docSlug": "7e995254b839b7fbb7e998df4127a7b8", "documentTitle": "ATAI | Investor Presentation Deck | 33 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "solution", "function": "present_solution", "notes": "Uses a hierarchical structure to break down the objective into three strategic pillars.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2806-77f1-979f-2c5838bae35a/4", "deckHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a", "deckAnchorHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 4, "beatId": "6fa85486-4050-455b-83f4-0a7d98cd76f0", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The deck outlines atai Life Sciences' solution, including the combination of rapid acting intervention, psychological support, and precision to achieve sustained behavioural change in patients.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2806-77f1-979f-2c5838bae35a", "docSlug": "7e995254b839b7fbb7e998df4127a7b8", "documentTitle": "ATAI | Investor Presentation Deck | 33 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a Gantt-style visualization to show the progress of drug development programs.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2806-77f1-979f-2c5838bae35a/5", "deckHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a", "deckAnchorHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a#slide-5", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 4, "beatId": "6fa85486-4050-455b-83f4-0a7d98cd76f0", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The deck outlines atai Life Sciences' solution, including the combination of rapid acting intervention, psychological support, and precision to achieve sustained behavioural change in patients.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" }, { "to": 6, "from": 5, "beatId": "2bf82b33-c322-4f04-aa0f-63d81653966f", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Roadmap", "beatSlug": null, "evidence": "The deck presents a roadmap for atai Life Sciences, including expected milestones and cash runway into 2025.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2806-77f1-979f-2c5838bae35a", "docSlug": "7e995254b839b7fbb7e998df4127a7b8", "documentTitle": "ATAI | Investor Presentation Deck | 33 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a timeline framework to communicate both past achievements and future R&D milestones.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2806-77f1-979f-2c5838bae35a/6", "deckHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a", "deckAnchorHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 6, "from": 5, "beatId": "2bf82b33-c322-4f04-aa0f-63d81653966f", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Roadmap", "beatSlug": null, "evidence": "The deck presents a roadmap for atai Life Sciences, including expected milestones and cash runway into 2025.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2806-77f1-979f-2c5838bae35a", "docSlug": "7e995254b839b7fbb7e998df4127a7b8", "documentTitle": "ATAI | Investor Presentation Deck | 33 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2806-77f1-979f-2c5838bae35a/7", "deckHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a", "deckAnchorHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a#slide-7", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2806-77f1-979f-2c5838bae35a", "docSlug": "7e995254b839b7fbb7e998df4127a7b8", "documentTitle": "ATAI | Investor Presentation Deck | 33 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "problem_statement", "function": "frame_problem", "notes": "Uses a vertical timeline-style list to present the 'Huge Need for Development' metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2806-77f1-979f-2c5838bae35a/8", "deckHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a", "deckAnchorHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 9, "from": 8, "beatId": "1052cee1-7a23-4cec-85ca-0092145b37ba", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The deck presents problem statements for various mental health indications, highlighting the unmet need for effective treatments.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2806-77f1-979f-2c5838bae35a", "docSlug": "7e995254b839b7fbb7e998df4127a7b8", "documentTitle": "ATAI | Investor Presentation Deck | 33 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "traction", "function": "show_traction", "notes": "Includes a quote from Keith Nuechterlein and specific Cohen's d effect size metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2806-77f1-979f-2c5838bae35a/9", "deckHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a", "deckAnchorHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 9, "from": 8, "beatId": "1052cee1-7a23-4cec-85ca-0092145b37ba", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The deck presents problem statements for various mental health indications, highlighting the unmet need for effective treatments.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" }, { "to": 10, "from": 9, "beatId": "c03b4929-2253-4e87-9891-73e59cfb766a", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The deck showcases traction for various programs, including RL-007, COMP360, and GRX-917, demonstrating progress and potential for growth.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2806-77f1-979f-2c5838bae35a", "docSlug": "7e995254b839b7fbb7e998df4127a7b8", "documentTitle": "ATAI | Investor Presentation Deck | 33 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a vertical process flow to demonstrate clinical progression and de-risking.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2806-77f1-979f-2c5838bae35a/10", "deckHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a", "deckAnchorHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 10, "from": 9, "beatId": "c03b4929-2253-4e87-9891-73e59cfb766a", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The deck showcases traction for various programs, including RL-007, COMP360, and GRX-917, demonstrating progress and potential for growth.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2806-77f1-979f-2c5838bae35a", "docSlug": "7e995254b839b7fbb7e998df4127a7b8", "documentTitle": "ATAI | Investor Presentation Deck | 33 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "traction", "function": "show_traction", "notes": "The slide highlights the efficacy of RL-007 in cognitive endpoints during a Phase 2 study.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2806-77f1-979f-2c5838bae35a/11", "deckHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a", "deckAnchorHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a#slide-11", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2806-77f1-979f-2c5838bae35a", "docSlug": "7e995254b839b7fbb7e998df4127a7b8", "documentTitle": "ATAI | Investor Presentation Deck | 33 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "appendix_methodology", "function": "present_framework", "notes": "The slide uses a standard clinical trial flow diagram to illustrate the study protocol.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2806-77f1-979f-2c5838bae35a/12", "deckHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a", "deckAnchorHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a#slide-12", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2806-77f1-979f-2c5838bae35a", "docSlug": "7e995254b839b7fbb7e998df4127a7b8", "documentTitle": "ATAI | Investor Presentation Deck | 33 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses a feature-comparison matrix to highlight the competitive advantage of RL-007.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2806-77f1-979f-2c5838bae35a/13", "deckHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a", "deckAnchorHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a#slide-13", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2806-77f1-979f-2c5838bae35a", "docSlug": "7e995254b839b7fbb7e998df4127a7b8", "documentTitle": "ATAI | Investor Presentation Deck | 33 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2806-77f1-979f-2c5838bae35a/14", "deckHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a", "deckAnchorHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a#slide-14", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2806-77f1-979f-2c5838bae35a", "docSlug": "7e995254b839b7fbb7e998df4127a7b8", "documentTitle": "ATAI | Investor Presentation Deck | 33 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "problem_statement", "function": "frame_problem", "notes": "The slide uses a split-layout: left side defines the disease and market size, right side outlines the clinical 'urgent need' for innovation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2806-77f1-979f-2c5838bae35a/15", "deckHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a", "deckAnchorHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a#slide-15", "loopMatches": [ { "to": 16, "from": 15, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "8f5a575a-6ced-4f97-a957-76a471eb55b9", "evidence": "The deck emphasizes the unmet need for effective treatments in depression, highlighting the potential consequences of inaction.", "position": 0, "objective": "Highlight the urgent need for innovation in depression treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2806-77f1-979f-2c5838bae35a", "docSlug": "7e995254b839b7fbb7e998df4127a7b8", "documentTitle": "ATAI | Investor Presentation Deck | 33 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a line chart to demonstrate the efficacy of different dosages of COMP360 over 12 weeks.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2806-77f1-979f-2c5838bae35a/16", "deckHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a", "deckAnchorHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a#slide-16", "loopMatches": [ { "to": 16, "from": 15, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "8f5a575a-6ced-4f97-a957-76a471eb55b9", "evidence": "The deck emphasizes the unmet need for effective treatments in depression, highlighting the potential consequences of inaction.", "position": 0, "objective": "Highlight the urgent need for innovation in depression treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2806-77f1-979f-2c5838bae35a", "docSlug": "7e995254b839b7fbb7e998df4127a7b8", "documentTitle": "ATAI | Investor Presentation Deck | 33 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a timeline-based process diagram to illustrate clinical trial protocols.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2806-77f1-979f-2c5838bae35a/17", "deckHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a", "deckAnchorHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a#slide-17", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2806-77f1-979f-2c5838bae35a", "docSlug": "7e995254b839b7fbb7e998df4127a7b8", "documentTitle": "ATAI | Investor Presentation Deck | 33 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "executive_summary", "function": "summarize", "notes": "The slide uses a split layout: a left-hand sidebar for product summary and a right-hand side for clinical data visualization.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2806-77f1-979f-2c5838bae35a/18", "deckHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a", "deckAnchorHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a#slide-18", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2806-77f1-979f-2c5838bae35a", "docSlug": "7e995254b839b7fbb7e998df4127a7b8", "documentTitle": "ATAI | Investor Presentation Deck | 33 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "executive_summary", "function": "summarize", "notes": "The slide uses a dark sidebar for product specs and a white main area for trial design and results.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2806-77f1-979f-2c5838bae35a/19", "deckHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a", "deckAnchorHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a#slide-19", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2806-77f1-979f-2c5838bae35a", "docSlug": "7e995254b839b7fbb7e998df4127a7b8", "documentTitle": "ATAI | Investor Presentation Deck | 33 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2806-77f1-979f-2c5838bae35a/20", "deckHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a", "deckAnchorHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a#slide-20", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2806-77f1-979f-2c5838bae35a", "docSlug": "7e995254b839b7fbb7e998df4127a7b8", "documentTitle": "ATAI | Investor Presentation Deck | 33 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "problem_statement", "function": "frame_problem", "notes": "The slide uses a combination of a disease overview, market sizing metrics, and a 'massive unaddressed need' framework to justify the problem.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2806-77f1-979f-2c5838bae35a/21", "deckHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a", "deckAnchorHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2806-77f1-979f-2c5838bae35a", "docSlug": "7e995254b839b7fbb7e998df4127a7b8", "documentTitle": "ATAI | Investor Presentation Deck | 33 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "executive_summary", "function": "summarize", "notes": "Includes a comparison chart of Etifoxine vs Lorazepam and a summary of Phase 1 trial design.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2806-77f1-979f-2c5838bae35a/22", "deckHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a", "deckAnchorHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a#slide-22", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2806-77f1-979f-2c5838bae35a", "docSlug": "7e995254b839b7fbb7e998df4127a7b8", "documentTitle": "ATAI | Investor Presentation Deck | 33 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "traction", "function": "analyze_data", "notes": "Includes detailed TEAE (Treatment-emergent Adverse Event) breakdown by dose cohort.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2806-77f1-979f-2c5838bae35a/23", "deckHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a", "deckAnchorHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a#slide-23", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2806-77f1-979f-2c5838bae35a", "docSlug": "7e995254b839b7fbb7e998df4127a7b8", "documentTitle": "ATAI | Investor Presentation Deck | 33 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "traction", "function": "show_traction", "notes": "The slide uses topographical brain maps to visualize EEG data changes across three cohorts (Placebo, Low Dose, High Dose).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2806-77f1-979f-2c5838bae35a/24", "deckHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a", "deckAnchorHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a#slide-24", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2806-77f1-979f-2c5838bae35a", "docSlug": "7e995254b839b7fbb7e998df4127a7b8", "documentTitle": "ATAI | Investor Presentation Deck | 33 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "appendix_data", "function": "analyze_data", "notes": "The chart displays pharmacodynamic data with error bars and significance markers (asterisks).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2806-77f1-979f-2c5838bae35a/25", "deckHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a", "deckAnchorHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a#slide-25", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2806-77f1-979f-2c5838bae35a", "docSlug": "7e995254b839b7fbb7e998df4127a7b8", "documentTitle": "ATAI | Investor Presentation Deck | 33 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "comparison_table", "function": "compare_peers", "notes": "The slide uses a checkmark matrix to highlight the competitive advantages of the proposed drug.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2806-77f1-979f-2c5838bae35a/26", "deckHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a", "deckAnchorHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a#slide-26", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2806-77f1-979f-2c5838bae35a", "docSlug": "7e995254b839b7fbb7e998df4127a7b8", "documentTitle": "ATAI | Investor Presentation Deck | 33 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2806-77f1-979f-2c5838bae35a/27", "deckHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a", "deckAnchorHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a#slide-27", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2806-77f1-979f-2c5838bae35a", "docSlug": "7e995254b839b7fbb7e998df4127a7b8", "documentTitle": "ATAI | Investor Presentation Deck | 33 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "problem_statement", "function": "frame_problem", "notes": "Uses a timeline-style visual to list key statistics about the OUD crisis.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2806-77f1-979f-2c5838bae35a/28", "deckHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a", "deckAnchorHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a#slide-28", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2806-77f1-979f-2c5838bae35a", "docSlug": "7e995254b839b7fbb7e998df4127a7b8", "documentTitle": "ATAI | Investor Presentation Deck | 33 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "executive_summary", "function": "summarize", "notes": "Includes a line chart showing HCQN subscale scores over time and a two-stage clinical trial design diagram.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2806-77f1-979f-2c5838bae35a/29", "deckHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a", "deckAnchorHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a#slide-29", "loopMatches": [ { "to": 30, "from": 29, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "881a7577-25cc-41b7-b2fe-88ebe2283b82", "evidence": "The deck presents a sense of urgency, highlighting the potential for growth and innovation in the mental health space.", "position": 1, "objective": "Explain why now is the right time for atai Life Sciences' solutions", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 0.6, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2806-77f1-979f-2c5838bae35a", "docSlug": "7e995254b839b7fbb7e998df4127a7b8", "documentTitle": "ATAI | Investor Presentation Deck | 33 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses a checkmark-based comparison matrix to highlight the unique value proposition of DMX-1002.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2806-77f1-979f-2c5838bae35a/30", "deckHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a", "deckAnchorHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a#slide-30", "loopMatches": [ { "to": 30, "from": 29, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "881a7577-25cc-41b7-b2fe-88ebe2283b82", "evidence": "The deck presents a sense of urgency, highlighting the potential for growth and innovation in the mental health space.", "position": 1, "objective": "Explain why now is the right time for atai Life Sciences' solutions", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 0.6, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2806-77f1-979f-2c5838bae35a", "docSlug": "7e995254b839b7fbb7e998df4127a7b8", "documentTitle": "ATAI | Investor Presentation Deck | 33 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2806-77f1-979f-2c5838bae35a/31", "deckHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a", "deckAnchorHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a#slide-31", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-2806-77f1-979f-2c5838bae35a", "docSlug": "7e995254b839b7fbb7e998df4127a7b8", "documentTitle": "ATAI | Investor Presentation Deck | 33 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a structured card-based layout to present four distinct business units.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-2806-77f1-979f-2c5838bae35a/32", "deckHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a", "deckAnchorHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a#slide-32", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }